Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
Return to: PBR Home | Automation
Today in Automation

Automation

Boehringer to use Circuit optogenetics technology to develop new obesity drugs Boehringer Ingelheim has entered into a second collaboration with US-based Circuit Therapeutics to use its optogenetics technology platform for the discovery and development of new medicines to treat obesity and associated diseases. Automation > IT & Software > News

Latest Automation News by Sector

Select a sector from the list or browse by sector below:

IT & Software

Minerva licenses Sendai Virus technology for stem cell generation
Minerva Biotechnologies and ID Pharma (formerly DNAVEC) announced that they have signed an agreement granting Minerva worldwide rights to use and commercialize their non-integrating Sendai virus vectors, together with Minerva’s proprietary technology, for generating Induced Pluripotent Stem (iPS) cells.
Automation > IT & Software > News
Allied-Bristol Life Sciences licenses Yale University's platform technology and lead molecules
By PBR Staff Writer
Allied-Bristol Life Sciences (ABLS) has entered into a worldwide licensing agreement with Yale University for a proprietary platform technology and associated lead molecules to further developed new treatments for diseases such as prostate cancer.
Automation > IT & Software > News

Laboratory Instrumentation

Cepheid, pharma firms collaborate on diagnostic test for multidrug-resistant bacterial infections
By PBR Staff Writer
Cepheid has entered into a new collaboration with AstraZeneca, Cubist and GSK to encourage transformational change in infectious disease therapy.
Automation > Laboratory Instrumentation > News
BioLight announces start of clinical study with DiagnosTear dry eye syndrome diagnostic assay
BioLight Life Sciences Investments announced that DiagnosTear has received all necessary approvals from Sheba Medical Center near Tel Aviv to begin a clinical study with its TeaRx, point-of-care Dry Eye Syndrome diagnostic assay. DiagnosTear is part of BioLight’s XLVision Sciences ophthalmology cluster.
Automation > Laboratory Instrumentation > News